These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 3584851

  • 1. Rebound elevation of cortisol following cyproheptadine withdrawal in Cushing's disease from a pituitary macroadenoma.
    Ooi TC, Twum-Barima Y.
    J Endocrinol Invest; 1987 Apr; 10(2):107-9. PubMed ID: 3584851
    [Abstract] [Full Text] [Related]

  • 2. Cyproheptadine treatment in Cushing's disease.
    Tanakol R, Alagöl F, Azizlerli H, Sandalci O, Terzioğlu T, Berker F.
    J Endocrinol Invest; 1996 Apr; 19(4):242-7. PubMed ID: 8862505
    [Abstract] [Full Text] [Related]

  • 3. Cyproheptadine-induced remission of Cushing's disease due to pituitary basophil adenoma.
    Jimenez-Alonso J, Munoz-Avila J, Jaimez L, Pérez-Jimenez F, Bellido C, Jiménez-Perepérez JA.
    Drug Intell Clin Pharm; 1982 Dec; 16(12):962-5. PubMed ID: 6295736
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cyproheptadine may act at the pituitary in Cushing's disease: evidence from CRF stimulation.
    Tucci JR, Nowakowski KJ, Jackson IM.
    J Endocrinol Invest; 1989 Mar; 12(3):197-200. PubMed ID: 2542391
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Transitory remission of hypercorticism by means of cyproheptadine in a patient with Cushing syndrome].
    Vetter W, Vetter H, Beckerhoff R, Würsten D, Siegenthaler W.
    Schweiz Med Wochenschr; 1976 Sep 25; 106(39):1320-2. PubMed ID: 1034340
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pituitary macroadenoma and Cushing's disease in pediatric patients: patient report and review of the literature.
    Damiani D, Aguiar CH, Crivellaro CE, Galvão JA, Dichtchekenian V, Setian N.
    J Pediatr Endocrinol Metab; 1998 Sep 25; 11(5):665-9. PubMed ID: 9829219
    [Abstract] [Full Text] [Related]

  • 13. The effect of cyproheptadine and/or bromocriptine on plasma ACTH levels in patients cured of Cushing's disease by bilateral adrenalectomy.
    Whitehead HM, Beacom R, Sheridan B, Atkinson AB.
    Clin Endocrinol (Oxf); 1990 Feb 25; 32(2):193-201. PubMed ID: 2161298
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cyproheptadine in the control of Cushing's disease.
    Hsu TH, Gann DS, Tsan KW, Russell RP.
    Johns Hopkins Med J; 1981 Aug 25; 149(2):77-83. PubMed ID: 6265685
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cushing's disease due to female gonadotroph adenoma of the pituitary.
    Ikeda H, Yoshimoto T, Kovacs K, Horvath E.
    Clin Endocrinol (Oxf); 1995 Sep 25; 43(3):383-6. PubMed ID: 7586610
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. An unusual case of Cushing's syndrome due to bihormonal ACTH-prolactin secreting pituitary macroadenoma with rapid response to cabergoline.
    Kunasegaran S, Croxson MS, Holdaway I, Murphy R.
    BMJ Case Rep; 2017 Aug 07; 2017():. PubMed ID: 28784879
    [Abstract] [Full Text] [Related]

  • 20. Nelson's syndrome: complete remission with cabergoline but not with bromocriptine or cyproheptadine treatment.
    Casulari LA, Naves LA, Mello PA, Pereira Neto A, Papadia C.
    Horm Res; 2004 Aug 07; 62(6):300-5. PubMed ID: 15557761
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.